IRADIMED CORPORATION - COMMON STOCK
41.47
25-April-24 15:59:51
15 minutes delayed
Stocks
-0.97
-2.29%
Today's range
41.17 - 42.15
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months High: IRADIMED CORPORATION - COMMON STOCK
09 May 2023 11:38:12 By NetDania Notify
-
NetDania - New 12 months High: IRADIMED CORPORATION - COMMON STOCK
08 May 2023 13:52:30 By NetDania Notify
-
NetDania - New 12 months High: IRADIMED CORPORATION - COMMON STOCK
05 May 2023 09:45:09 By NetDania Notify
-
NetDania - New 12 months High: IRADIMED CORPORATION - COMMON STOCK
04 May 2023 09:45:03 By NetDania Notify
-
IRADIMED CORPORATION Announces First Quarter 2023 Financial Results
04 May 2023 08:30:01 By Nasdaq GlobeNewswire
-
NetDania - New 12 months High: IRADIMED CORPORATION - COMMON STOCK
03 May 2023 11:02:41 By NetDania Notify
-
IRADIMED CORPORATION to Hold 2023 First Quarter Financial Results Conference Call on May 4th
27 Apr 2023 08:30:01 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION To Present at the 35th Annual Roth Conference
06 Mar 2023 08:45:00 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Issues Urgent Medical Device Correction
24 Feb 2023 16:15:00 By Nasdaq GlobeNewswire
-
02 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Fourth Quarter Financial Results Conference Call on February 2nd
26 Jan 2023 10:30:00 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Preliminary Financial Results for Fourth Quarter 2022
18 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Third Quarter 2022 Financial Results
03 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Third Quarter Financial Results Conference Call on November 3rd
27 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Withdraws 510(k) with Plans to Resubmit After Further Discussions with FDA
10 Oct 2022 08:00:00 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Appointment of Hilda Scharen-Guivel to Board of Directors
06 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION Announces Second Quarter 2022 Financial Results
29 Jul 2022 11:00:10 By Nasdaq GlobeNewswire
-
28 Jul 2022 13:56:57 By Nasdaq GlobeNewswire
-
IRADIMED CORPORATION to Hold 2022 Second Quarter Financial Results Conference Call on July 29th
22 Jul 2022 16:30:00 By Nasdaq GlobeNewswire
-
IRADIMED Names John F. Glenn Chief Financial Officer
26 May 2022 16:05:00 By Nasdaq GlobeNewswire